Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
Clinical and Molecular Hepatology · 2024
DOI: 10.3350/cmh.2024.0115 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical and Molecular Hepatology, 2024. Verfasst von Pin-Nan Cheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Education.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
- School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver, National Sun Yat-sen University, Kaohsiung, Taiwan.
Förderung
- Ministry of Education
Zitieren
APA
Cheng, P. N., & Yu, M. L. (2024). Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0115
Vancouver
Cheng PN, Yu ML. Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer. Clinical and Molecular Hepatology. 2024. doi:10.3350/cmh.2024.0115
BibTeX
@article{Cheng2024,
author = {Cheng, Pin-Nan and Yu, Ming-Lung},
title = {Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer},
journal = {Clinical and Molecular Hepatology},
year = {2024},
doi = {10.3350/cmh.2024.0115}
}
EUVIMED